(ATDN) G-CSF

(ATDN) G-CSF

Treatment Review No. 10; March 1994

G-CSF, or Neupogen, encourages the growth of white blood cells. This drug is approved for the treatment of blood cell growth in people with AIDS. A study of G-CSF for the treatment of neutropenia, which is the loss of white blood cells, is open at different sites around the country. These studies will be reviewed in the next edition of The Experimental Treatment Guide, The Network's directory of clinical trials and treatment programs. An article on G-CSF and this study is on the back page of this issue of Treatment Review.

940301
ATR01007

Always watch for outdated information. This article first appeard in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1994 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1994. AEGIS.